BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14103649)

  • 1. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. III. CIRCULATING ANTIBODY FORMATION AS A RESPONSE TO ANTIGENIC STIMULUS IN LEUKAEMIA, MALIGNANT LYMPHOMA, MYELOMA AND MYELOFIBROSIS.
    LIBANSKY J
    Neoplasma; 1963; 10():621-39. PubMed ID: 14103649
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDY OF IMMUNOLOGIC REACTIVITY IN HEMOBLASTOSIS. CIRCULATING ANTIBODY FORMATION AS A RESPONSE TO ANTIGENIC STIMULUS IN LEUKEMIA, MALIGNANT LYMPHOMA, MYELOMA AND MYELOFIBROSIS.
    LIBANSKY J
    Blood; 1965 Feb; 25():169-78. PubMed ID: 14267693
    [No Abstract]   [Full Text] [Related]  

  • 3. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. IV. THE BACTERICIDAL PROPERTIES OF THE SERUM AGAINST GRAM-POSITIVE MICROBES IN PATIENTS SUFFERING FROM LEUKAEMIA, MALIGNANT LYMPHOMA, MYELOMA, AND MYELOFIBROSIS.
    LIBANSKY J; JEZKOVA Z
    Neoplasma; 1964; 11():71-87. PubMed ID: 14116776
    [No Abstract]   [Full Text] [Related]  

  • 4. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. II. BLOOD COMPLEMENT VALUES IN LEUKAEMIA, MALIGNANT LYMPHOMA, AND MYELOMA.
    LIBANSKY J; JEZKOVA Z
    Neoplasma; 1963; 10():605-19. PubMed ID: 14103648
    [No Abstract]   [Full Text] [Related]  

  • 5. INVESTIGATIONS ON THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. I. PROPERDIN VALUES IN LEUKAEMIAS, MALIGNANT LYMPHOMAS AND MYELOMAS.
    LIBANSKY J; RYBAK M
    Neoplasma; 1963; 10():261-82. PubMed ID: 14049078
    [No Abstract]   [Full Text] [Related]  

  • 6. ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
    MORROW LB; ANDERSON RE
    Arch Pathol; 1965 May; 79():484-93. PubMed ID: 14289001
    [No Abstract]   [Full Text] [Related]  

  • 7. [STIMULATION OF NEUTROPHILIA BY A POLYSACCHARIDE EXTRACT OF "VISCUM ALBUM". ITS THERAPEUTIC USE IN NEUTROPENIA].
    MATHE G; SCHNEIDER M; AMIEL JL; CATTAN A; SCHWARZENBERG L; BERNO M
    Rev Fr Etud Clin Biol; 1963 Dec; 8():1017-20. PubMed ID: 14102503
    [No Abstract]   [Full Text] [Related]  

  • 8. [TUBERCULIN ANERGY AS A CRITERION OF BIOLOGICAL DELIMITATION OF MALIGNANT RETICULOPATHIES].
    POPA M; POPA G; VEIZA L
    Med Interna (Bucur); 1964 Jul; 16():811-8. PubMed ID: 14182762
    [No Abstract]   [Full Text] [Related]  

  • 9. The investigation of the immunological reactivity of patients with haemoblastosis.
    Libánský J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
    [No Abstract]   [Full Text] [Related]  

  • 10. [RADIOTHERAPY OF BLOOD DISEASES].
    CAPUA A
    Riforma Med; 1964 May; 78():573-82. PubMed ID: 14170522
    [No Abstract]   [Full Text] [Related]  

  • 11. 5 YEARS EXPERIENCE WITH DIFFERENT N-LOST-PHOSPHAMIDESTERS IN TUMOR CHEMOTHERAPY.
    GROSS R
    Acta Unio Int Contra Cancrum; 1964; 20():369-72. PubMed ID: 14151932
    [No Abstract]   [Full Text] [Related]  

  • 12. PRODUCTION OF ANTIBODIES AGAINST VIRUSES IN LEUKAEMIA AND RELATED DISEASES.
    HEATH RB; FAIRLEY GH; MALPAS JS
    Br J Haematol; 1964 Jul; 10():365-70. PubMed ID: 14179491
    [No Abstract]   [Full Text] [Related]  

  • 13. THE TREATMENT OF LEUKAEMIA AND ALLIED DISORDERS.
    INNES J
    Br J Clin Pract; 1964 Nov; 18():681-7. PubMed ID: 14230850
    [No Abstract]   [Full Text] [Related]  

  • 14. [INDICATIONS AND CONTRAINDICATIONS FOR CORTISOL DERIVATIVES IN HEMATOLOGY].
    CLEMENT F
    Rev Med Suisse Romande; 1964 Jan; 84():67-76. PubMed ID: 14134790
    [No Abstract]   [Full Text] [Related]  

  • 15. [RESEARCH ON THE LEUKOCYTE ALKALINE PHOSPHATASE ACTIVITY. II. NON-LEUKEMIC HISTIOCYTIC SARCOMATOSIS].
    SASSO GF; MANCINI P
    Med Clin Sper; 1964; 14():63-70. PubMed ID: 14184164
    [No Abstract]   [Full Text] [Related]  

  • 16. [SEMEIOLOGICAL ASPECTS OF THE PLEUROPULMONARY LOCALIZATIONS OF SYSTEMIC HISTIOCYTIC SARCOMATOSIS].
    DEPASQUALE C; GIANNANDREA G
    Med Clin Sper; 1963; 13():544-82. PubMed ID: 14160599
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE CLINICAL USE OF CYCLOPHOSPHAMIDE IN MALIGNANT HEMOPATHIES. EVALUATION OF THE RESULTS].
    JAMRA M; MILDER RV; VENTURELLI E
    Rev Assoc Med Bras; 1963 Jun; 9():191-202. PubMed ID: 14096204
    [No Abstract]   [Full Text] [Related]  

  • 18. [ATTEMPT AT TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS WITH 1-METHYL-2-P-ALLOPHANOYL-BENZYLHYDRAZINE HYDROBROMIDE].
    MATHE G; SCHNEIDER M; CATTAN A; AMIEL JL; SCHWARZENBERG L; SCHLUMBERGER JR
    Rev Fr Etud Clin Biol; 1964 Nov; 9():990-2. PubMed ID: 14232681
    [No Abstract]   [Full Text] [Related]  

  • 19. CHLORAMBUCIL THERAPY FOR LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA.
    EZDINLI EZ; STUTZMAN L
    JAMA; 1965 Feb; 191():444-50. PubMed ID: 14238023
    [No Abstract]   [Full Text] [Related]  

  • 20. [OVER-ALL STUDY OF THE MALIGNANT LYMPHOMAS].
    MALLARME J
    Rev Prat; 1964 May; 14():1713-43. PubMed ID: 14147345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.